ID OVISE AC CVCL_3116 DR BTO; BTO_0003498 DR CLO; CLO_0037097 DR EFO; EFO_0006724 DR ArrayExpress; E-MTAB-2706 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR BioGRID_ORCS_Cell_line; 983 DR BioSample; SAMN02800475 DR BioSample; SAMN03472858 DR BioSample; SAMN10988266 DR cancercelllines; CVCL_3116 DR Cell_Model_Passport; SIDM00564 DR CGH-DB; 330-2 DR Cosmic; 1223316 DR Cosmic; 1328065 DR Cosmic; 1434893 DR Cosmic; 1708377 DR Cosmic; 1995606 DR Cosmic; 2074246 DR Cosmic; 2482699 DR Cosmic-CLP; 1240198 DR DepMap; ACH-000527 DR EGA; EGAS00001000610 DR EGA; EGAS00001000978 DR GDSC; 1240198 DR GEO; GSM416678 DR GEO; GSM659395 DR GEO; GSM827222 DR GEO; GSM888567 DR GEO; GSM1176280 DR GEO; GSM1670321 DR IARC_TP53; 30140 DR JCRB; JCRB1043 DR JCRB; NIHS0296 DR JCRB; NIHS0338 DR LiGeA; CCLE_251 DR LINCS_LDP; LCL-1524 DR PharmacoDB; OVISE_1222_2019 DR PRIDE; PXD000901 DR PRIDE; PXD003105 DR PRIDE; PXD003668 DR PRIDE; PXD030304 DR Progenetix; CVCL_3116 DR Wikidata; Q54937026 RX DOI=10.5795/jjscc.31.966; RX PubMed=7535723; RX PubMed=9328139; RX PubMed=11121861; RX PubMed=15677628; RX PubMed=17671176; RX PubMed=20081105; RX PubMed=20215515; RX PubMed=22460905; RX PubMed=22705003; RX PubMed=23839242; RX PubMed=24023729; RX PubMed=25485619; RX PubMed=25877200; RX PubMed=25984343; RX PubMed=26388441; RX PubMed=26589293; RX PubMed=26972028; RX PubMed=27141528; RX PubMed=27397505; RX PubMed=27561551; RX PubMed=28196595; RX PubMed=30485824; RX PubMed=30894373; RX PubMed=30971826; RX PubMed=31068700; RX PubMed=35839778; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: MD Anderson Cell Lines Project. CC Population: Japanese. CC Doubling time: 60 hours (PubMed=7535723; PubMed=9328139; PubMed=11121861); 48 hours (PubMed=25984343); ~1.5 days (Note=Lots 04092007 and 06132011), ~49 hours (Note=Lot 05302016) (JCRB=JCRB1043). CC HLA typing: A*26:01,31:01; B*40:02,51:01; C*03:04,14:02; DRB1*11:30,11:30 (PubMed=26589293). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (DepMap=ACH-000527). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Genomics; Whole genome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Phenotyping; shRNA library screening. CC Omics: Proteomics. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Proteomics; PTM; GPI-anchored proteins. CC Omics: Proteomics; PTM; Phosphorylation; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.05%; Native American=0%; East Asian, North=80.54%; East Asian, South=17.28%; South Asian=0%; European, North=0%; European, South=2.13% (PubMed=30894373). CC Discontinued: JCRB; NIHS0296; true. CC Discontinued: JCRB; NIHS0338; true. CC Derived from site: Metastatic; Pelvis, innominate bone; UBERON=UBERON_0001272. ST Source(s): Cosmic-CLP=1240198; JCRB=JCRB1043; PubMed=25877200; PubMed=30485824 ST Amelogenin: X ST CSF1PO: 9,11 ST D13S317: 11,12 ST D16S539: 9 ST D18S51: 19 ST D21S11: 28,30 ST D3S1358: 14,15 ST D5S818: 10 ST D7S820: 11,12 ST D8S1179: 15,16 ST FGA: 19,23 ST Penta D: 9,11 ST Penta E: 14 ST TH01: 9,9.3 (Cosmic-CLP=1240198; JCRB=JCRB1043; PubMed=25877200) ST TH01: 9.3 (PubMed=30485824) ST TPOX: 8 ST vWA: 18 DI NCIt; C40078; Ovarian clear cell adenocarcinoma DI ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 40Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 41 CH CVCL_U211 ! OVISE-3 // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=26972028; DOI=10.1016/j.jprot.2016.03.008; RA Masuishi, Yusuke RA Kimura, Yayoi RA Arakawa, Noriaki RA Hirano, Hisashi RT "Identification of glycosylphosphatidylinositol-anchored proteins and RT omega-sites using TiO2-based affinity purification followed by RT hydrogen fluoride treatment."; RL J. Proteomics 139:77-83(2016). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652; RA Cowley, Glenn S. RA Weir, Barbara A. RA Vazquez, Francisca RA Tamayo, Pablo RA Scott, Justine A. RA Rusin, Scott RA East-Seletsky, Alexandra RA Ali, Levi D. RA Gerath, William F.J. RA Pantel, Sarah E. RA Lizotte, Patrick Hall RA Jiang, Guo-Zhi RA Hsiao, Jessica RA Tsherniak, Aviad RA Dwinell, Elizabeth RA Aoyama, Simon RA Okamoto, Michael RA Harrington, William RA Gelfand, Ellen T. RA Green, Thomas M. RA Tomko, Mark J. RA Gopal, Shuba RA Wong, Terence C. RA Li, Hu-Bo RA Howell, Sara RA Stransky, Nicolas RA Liefeld, Ted RA Jang, Dongkeun RA Bistline, Jonathan RA Meyers, Barbara Hill RA Armstrong, Scott Allen RA Anderson, Kenneth Carl RA Stegmaier, Kimberly RA Reich, Michael RA Pellman, David RA Boehm, Jesse S. RA Mesirov, Jill P. RA Golub, Todd Robert RA Root, David E. RA Hahn, William Chun RT "Parallel genome-scale loss of function screens in 216 cancer cell RT lines for the identification of context-specific genetic RT dependencies."; RL Sci. Data 1:140035.1-140035.12(2014). // RX PubMed=23839242; DOI=10.1038/ncomms3126; PMCID=PMC3715866; RA Domcke, Silvia RA Sinha, Rileen RA Levine, Douglas A. RA Sander, Chris RA Schultz, Nikolaus RT "Evaluating cell lines as tumour models by comparison of genomic RT profiles."; RL Nat. Commun. 4:2126.1-2126.10(2013). // RX PubMed=24023729; DOI=10.1371/journal.pone.0072162; PMCID=PMC3762837; RA Anglesio, Michael S. RA Wiegand, Kimberly C. RA Melnyk, Nataliya RA Chow, Christine RA Salamanca, Clara M. RA Prentice, Leah M. RA Senz, Janine RA Yang, Winnie RA Spillman, Monique Ann RA Cochrane, Dawn R. RA Shumansky, Karey RA Shah, Sohrab P. RA Kalloger, Steve E. RA Huntsman, David G. RT "Type-specific cell line models for type-specific ovarian cancer RT research."; RL PLoS ONE 8:e72162.1-e72162.13(2013). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, Agda Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=20081105; DOI=10.1210/me.2009-0295; PMCID=PMC2817607; RA Nagaraja, Ankur K. RA Creighton, Chad Jeremy RA Yu, Zhi-Feng RA Zhu, Hui-Feng RA Gunaratne, Preethi H. RA Reid, Jeffrey G. RA Olokpa, Emuejevoke RA Itamochi, Hiroaki RA Ueno, Naoto Tada RA Hawkins, Shannon M. RA Anderson, Matthew Linley RA Matzuk, Martin Matthew RT "A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer."; RL Mol. Endocrinol. 24:447-463(2010). // RX PubMed=9328139; DOI=10.1038/bjc.1997.471; PMCID=PMC2228076; RA Yanagibashi, Takendo RA Gorai, Itsuo RA Nakazawa, Tsuneo RA Miyagi, Etsuko RA Hirahara, Fumiki RA Kitamura, Hitoshi RA Minaguchi, Hiroshi RT "Complexity of expression of the intermediate filaments of six new RT human ovarian carcinoma cell lines: new expression of cytokeratin RT 20."; RL Br. J. Cancer 76:829-835(1997). // RX PubMed=27141528; DOI=10.1016/j.dib.2016.04.001; PMCID=PMC4838930; RA Masuishi, Yusuke RA Kimura, Yayoi RA Arakawa, Noriaki RA Hirano, Hisashi RT "Data for identification of GPI-anchored peptides and omega-sites in RT cancer cell lines."; RL Data Brief 7:1302-1305(2016). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=7535723; DOI=10.1006/gyno.1995.1097; RA Gorai, Itsuo RA Nakazawa, Tsuneo RA Miyagi, Etsuko RA Hirahara, Fumiki RA Nagashima, Yoji RA Minaguchi, Hiroshi RT "Establishment and characterization of two human ovarian clear cell RT adenocarcinoma lines from metastatic lesions with different RT properties."; RL Gynecol. Oncol. 57:33-46(1995). // RX PubMed=27561551; DOI=10.1038/ncomms12645; PMCID=PMC5007461; RA Coscia, Fabian RA Watters, Karen M. RA Curtis, Marion RA Eckert, Mark A. RA Chiang, Chun-Yi RA Tyanova, Stefka RA Montag, Anthony RA Lastra, Ricardo R. RA Lengyel, Ernst Robert RA Mann, Matthias RT "Integrative proteomic profiling of ovarian cancer cell lines reveals RT precursor cell associated proteins and functional status."; RL Nat. Commun. 7:12645.1-12645.14(2016). // RX PubMed=30485824; DOI=10.1016/j.celrep.2018.10.096; PMCID=PMC6481945; RA Papp, Eniko RA Hallberg, Dorothy RA Konecny, Gottfried E. RA Bruhm, Daniel C. RA Adleff, Vilmos RA Noe, Michael RA Kagiampakis, Ioannis RA Palsgrove, Doreen RA Conklin, Dylan RA Kinose, Yasuto RA White, James R. RA Press, Michael Frederick RA Drapkin, Ronny I. RA Easwaran, Hariharan RA Baylin, Stephen Bruce RA Slamon, Dennis Joseph RA Velculescu, Victor E. RA Scharpf, Robert B. RT "Integrated genomic, epigenomic, and expression analyses of ovarian RT cancer cell lines."; RL Cell Rep. 25:2617-2633(2018). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). // RX PubMed=11121861; DOI=10.1016/S0304-3835(00)00605-4; RA Ohta, Ichiro RA Gorai, Itsuo RA Miyamoto, Yasunori RA Yang, Jun RA Zheng, Jian-Hua RA Kawata, Naomi RA Hirahara, Fumiki RA Shirotake, Shoichi RT "Cyclophosphamide and 5-fluorouracil act synergistically in ovarian RT clear cell adenocarcinoma cells."; RL Cancer Lett. 162:39-48(2001). // RX PubMed=15677628; DOI=10.1093/carcin/bgi032; RA Gorringe, Kylie Louise RA Chin, Suet-Feung RA Pharoah, Paul D.P. RA Staines, Joanne M. RA Oliveira, Carla RA Edwards, Paul A.W. RA Caldas, Carlos RT "Evidence that both genetic instability and selection contribute to RT the accumulation of chromosome alterations in cancer."; RL Carcinogenesis 26:923-930(2005). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=26388441; DOI=10.1016/j.cell.2015.08.056; PMCID=PMC4644236; RA Creixell, Pau RA Schoof, Erwin M. RA Simpson, Craig D. RA Longden, James RA Miller, Chad J. RA Lou, Hua Jane RA Perryman, Lara RA Cox, Thomas R. RA Zivanovic, Nevena RA Palmeri, Antonio RA Wesolowska-Andersen, Agata RA Helmer-Citterich, Manuela RA Ferkinghoff-Borg, Jesper RA Itamochi, Hiroaki RA Bodenmiller, Bernd RA Erler, Janine T. RA Turk, Benjamin E. RA Linding, Rune RT "Kinome-wide decoding of network-attacking mutations rewiring cancer RT signaling."; RL Cell 163:202-217(2015). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567; RA Kikuchi, Ryoko RA Tsuda, Hitoshi RA Kanai, Yae RA Kasamatsu, Takahiro RA Sengoku, Kazuo RA Hirohashi, Setsuo RA Inazawa, Johji RA Imoto, Issei RT "Promoter hypermethylation contributes to frequent inactivation of a RT putative conditional tumor suppressor gene connective tissue growth RT factor in ovarian cancer."; RL Cancer Res. 67:7095-7105(2007). // RX PubMed=22705003; DOI=10.1016/j.humpath.2012.03.011; RA Rahman, Munmun RA Nakayama, Kentaro RA Rahman, Mohammed Tanjimur RA Nakayama, Naomi RA Ishikawa, Masako RA Katagiri, Atsuko RA Iida, Kouji RA Nakayama, Satoru RA Otsuki, Yoshiro RA Shih, Ie-Ming RA Miyazaki, Kohji RT "Clinicopathologic and biological analysis of PIK3CA mutation in RT ovarian clear cell carcinoma."; RL Hum. Pathol. 43:2197-2206(2012). // RX DOI=10.5795/jjscc.31.966; RA Nakazawa, Tsuneo RA Gorai, Itsuo RA Doi, Chie RA Hirahara, Fumiki RA Minaguchi, Hiroshi RT "Establishment and characterization of human ovarian clear cell RT carcinoma cell line, OVISE."; RL Nihon Rinsho Saibo Gakkai Zasshi 31:966-972(1992). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). //